Ram Sasisekharan receives Agilent Thought Leader Award
Agilent Technologies Inc. announced that Dr Ram Sasisekharan, has received an Agilent Thought Leader Award in recognition of his contributions in the field of biologics characterization. A more efficient development of monoclonal antibodies (mAbs), against novel cancer targets and emerging pathogens is becoming critical, as the typical timeframe to develop these biopharmaceuticals from discovery to human clinical trials can be up to several years. This Agilent Thought Leader Award will help Dr Sasisekharan and his lab at the Massachusetts Institute of Technology (MIT) in Boston, continue to evolve their radically different approach that aims to shorten the development time between product ‘design’ to the clinic. The Sasisekharan team will focus on the advancement of analytical techniques for mAb characterization to explore the utilization of critical quality attribute measurements, earlier in the clone selection and drug development process, as a strategy to bring biologics to market faster.